Fatiha Merabet
Le Chesnay, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life study.
Journal: British journal of haematology
Published: October 02, 2025
Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine.
Journal: Frontiers in immunology
Published: November 09, 2024
Acquired hemophilia A and emicizumab for the treatment of bleeding: two case report and a literature review
Journal: Annales de biologie clinique
Published: August 16, 2024
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.
Journal: American journal of hematology
Published: March 04, 2024
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
Journal: British journal of haematology
Published: December 04, 2023
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia.
Journal: Blood advances
Published: February 15, 2022
A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia.
Journal: Haematologica
Published: September 17, 2021
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).
Journal: American journal of hematology
Published: June 02, 2021
Last Updated: 09/26/2026